Skip to Main Content

Paper Details

Proteomics discovery of pulmonary hypertension biomarkers: Insulin-like growth factor binding proteins are associated with disease severity.
Pulm Circ
6
2022
CA2, IGF, IGFBP1 and 2, IGFBP1, 2, 4, and 7, IGFBP1-7, IGFBP2, 4, and 7, IPAH, Insulin-like growth factor binding proteins, KLKB1, PAH, Plasma, Pulmonary arterial hypertension, carbonic anhydrase 2, idiopathic pulmonary arterial hypertension, insulin-like growth factor binding proteins, patients, plasma kallikrein, plasma samples, pulmonary hypertension, trypsin
Author NameAffiliation
Eric D Austinand Pulmonary Medicine Vanderbilt University Nashville Tennessee USA.
Dunbar IvyDepartment of Pediatric Cardiology Children's Hospital Colorado Aurora Colorado USA.
Jennifer E Van EykDivision of Cardiology Johns Hopkins University Baltimore Maryland USA.
Jennifer E Van EykAdvanced Clinical Biosystems Research Institute Cedars-Sinai Medical Center Los Angeles California USA.
Jennifer E Van EykDivision of Cardiology Johns Hopkins University Baltimore Maryland USA.
Jennifer E Van EykAdvanced Clinical Biosystems Research Institute Cedars-Sinai Medical Center Los Angeles California USA.
Allen D EverettDivision of Cardiology Johns Hopkins University Baltimore Maryland USA.
  • 1 - 7

Datasets

Release 1.2